The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma

BACKGROUND: Immune checkpoint inhibitors have been tried for several thoracic malignancies; however, their application as a neoadjuvant therapy in esophageal squamous cell carcinoma (ESCC) has not been studied. We evaluated the feasibility and safety of esophagectomy and total lymphadenectomy after...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Seong Yong, Hong, Min Hee, Kim, Hye Ryun, Lee, Chang Geol, Cho, Jae Ho, Cho, Byoung Chul, Kim, Dae Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711420/
https://www.ncbi.nlm.nih.gov/pubmed/33282345
http://dx.doi.org/10.21037/jtd-20-1088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711420/
https://www.ncbi.nlm.nih.gov/pubmed/33282345
http://dx.doi.org/10.21037/jtd-20-1088

Ejemplares similares